News

Sunshine Heart, C-Pulse, $2 million, loan, COUNTER HF, heart failure

Sunshine Heart Inc. has borrowed an additional $2 million to continue work on its U.S. pivotal study for the C-Pulse Heart Assist System. The minimally invasive surgically implanted device is...

fibrin, MSCs, stem cells, heart failure, Antoni Bayes-Genis, umbilical cord

To date, the only definitive treatment for heart failure – an organ transplant – is hampered by both the limited number of organ donors and the potential for the patient’s body to reject the new...

CardioMEMS, Scott & White Memorial, Texas, heart failure, remote monitoring

Scott & White Memorial – Temple for the first time implanted a new miniaturized, wireless monitoring sensor to help manage heart failure (HF). Scott & White Memorial is one of six...

ECRI Institute, review, Impella RP, Abiomed

ECRI Institute recently reviewed published data on Abiomed’s Impella RP (Right Percutaneous) transcatheter ventricular assist device (VAD). The institute said the device provides immediate...

UH Case Medical Center, Impella RP, first in Ohio, Abiomed, Mobile Learning Lab

University Hospitals Case Medical Center physicians in the Harrington Heart & Vascular Institute were the first in Ohio to implant a new device to treat right ventricular heart disease.

Beaumont Hospital Royal Oak, Impella RP, right-side heart failure, Abiomed

Beaumont Hospital, Royal Oak is one of the first centers in the United States to use a new minimally invasive heart pump designed to provide temporary support for patients with severe right-side...

CVRx, Barostim therapy, heart failure, trial, ESC-Heart Failure, Muller-Ehmsen

CVRx Inc. announced that positive results from the 'Barostim Therapy for Heart Failure' randomized, controlled clinical trial were presented at the ESC-Heart Failure 2015 Annual Conference in a...

cardiomems, st. jude medical, heart failure

Important new data presented during the Heart Rhythm Society's (HRS) 36th annual Scientific Session supporting improved outcomes and cost-effectiveness of the CardioMEMS HF System for the...

Big data in cardiology, social media big data analytics, data mining

The buzz term “big data” has made a rapid entry onto the healthcare scene in the past couple years with promises of improving healthcare, but there are still many who are trying to figure out how...

heart regeneration, zebrafish, epicardium, Duke, Poss

While the human heart can’t heal itself, the zebrafish heart can easily replace cells lost by damage or disease. Now, researchers have discovered properties of a mysterious outer layer of the...

gene therapy, stem cells, heart failure, mutations, Mount Sinai, Hajjar

Gene therapy can clip out genetic material linked to heart failure and replace it with normal genes, according to a study from the Cardiovascular Research Center at Icahn School of Medicine at...

transmyocardial laser revascularization

Transmyocardial laser revascularization (TMLR or TMR) was introduced in the late 1990s as a method to offer relief to patients with incapacitating angina that were poor candidates for other...

Biotronik, CLS, Itrevia, CRT-D, heart failure

Biotronik announced that a unique physiologic sensor is now available in the latest family of cardiac resynchronization therapy defibrillator (CRT-D) devices. Closed Loop Stimulation (CLS) is the...

Thoratec, HeartMate II, ROADMAP

Thoratec Corp. announced results from the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients...

Sunshine Heart, C-Pulse, COUNTER HF, FDA, review, pause, enrollment

Sunshine Heart Inc. announced that the U.S. Food and Drug Administration (FDA) has reviewed the company’s submission regarding the pause of the COUNTER HF U.S. pivotal study. The FDA has requested...

Several futuristic technologies and their potential impact on healthcare were discussed during the Future of Cardiovascular Medicine track sessions at the American College of Cardiology (ACC) 2015...

Biotronik, DX, ICD, Inventra, Itrevia, FDA, ultra-high energy

Biotronik announced that the U.S. Food and Drug Administration (FDA) has approved its DX line of implantable cardioverter defibrillators (ICDs) that can deliver ultra-high energy on the first...

Philips introduced CareSage at HIMSS 2015, which is new predictive analytics engine that enables health systems to better monitor and care for elderly patients by combining actionable insights...

Penn Medicine, congestive heart failure, readmissions, Health Recovery Solutions

Penn Medicine’s Penn Care at Home program reported a 53 percent reduction in 30-day readmission rates for 130 congestive heart failure patients since implementing software from Health Recovery...

EBR Systems Inc. announced it has raised $20 million for clinical studies and regulatory filings, including commitments toward a second quarter closing. EBR Systems is using the funds to build on...